HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive: Inhibition of HIF-1 with acriflavine reduced the colony formation and long-term culture capacity of primary CML cells and decreased the number of LSCs in vivo without a significant effect on normal cells44.